8-K

                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT

     Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934


         Date of Report (Date of earliest event reported): July 6, 2005


                          POLYPORE INTERNATIONAL, INC.
             (Exact name of registrant as specified in its charter)


    Delaware                          3999                       43-2049334
    --------                          ----                       ----------
(State or other                 (Commission File               (IRS Employer
jurisdiction of                      Number)                 Identification No.)
incorporation)

                             13800 South Lakes Drive
                               Charlotte, NC 28273

          (Address of principal executive offices, including zip code)

       Registrant's telephone number, including area code: (704) 587-8409
                                                           --------------

                                 Not Applicable
          (Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):

     [ ] Written communications pursuant to Rule 425 under the Securities Act
(17 CFR 230.425)

     [ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17
CFR 240.14a-12)

     [ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))

     [ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))



Item 1.01. Entry into a Material Definitive Agreement

     On July 6, 2005, Polypore International, Inc. (the "Company") entered into
an employment agreement with Robert B. Toth pursuant to which Mr. Toth will
serve as the Company's Chief Executive Officer and President and as the Chief
Executive Officer and President of the Company's subsidiary, Polypore, Inc. Mr.
Toth will serve on the Board of Directors of both companies (the "Board"). The
agreement has an initial term that runs until July 6, 2008 and is automatically
renewed for successive one year terms unless and until either party delivers
notice of termination within 120 days of the expiration of the then current
term. Mr. Toth's initial annual base salary is $450,000, which can be increased
(but not decreased) at the discretion of the Board. Additionally, on January 1,
2006, Mr. Toth's annual base salary will automatically be increased by 5%. While
Mr. Toth will generally be eligible for an annual cash bonus based solely on the
achievement of performance targets, his bonus for the 2005 fiscal year will be
at least equal to $225,000. Pursuant to the employment agreement, Mr. Toth was
granted options to purchase 4,152 shares of the Company's common stock. Subject
to the achievement of certain performance targets, such options will vest
ratable on each of the first four anniversaries of the date of grant. In
addition to his option grant, Mr. Toth will be entitled to purchase additional
shares of the Company's common stock during the first year of his employment
term at $875 per unit.

     If Mr. Toth's employment with the Company is terminated by the Company
without "cause" (as defined in the employment agreement), by Mr. Toth for "good
reason" (as defined in the employment agreement) or as a result of the Company's
election not to renew the term of employment, Mr. Toth will be entitled to (A)
all accrued and unpaid base salary, reimbursements and employee benefits through
the date of termination (the "Accrued Obligations"), (B) a lump sum payment of
an amount equal to the greater of (i) the aggregate remaining annual base salary
through the remainder of the then current term, or (ii) his then current annual
base salary, (C) a continuation of his employee benefits until the later of (i)
12 months, or (ii) the expiration of the then current term of employment, and
(D) a lump sun payment of an amount equal to the product of (i) the greater of
(a) one, or (b) a fraction, the numerator which equals the number of whole
months remaining in the then current term of employment (including the month of
termination) and the denominator which equals twelve, and (ii) the greater of
(a) Mr. Toth's annual bonus for the preceding fiscal year, and (b) 50% of Mr.
Toth's target bonus for the year of such termination. Additionally, upon the
Company's election not to renew the term of employment, Mr. Toth will be
entitled to his annual bonus for the year in which such expiration occurs, if
the Company achieves its performance targets for the year of such expiration. If
Mr. Toth's employment with the Company is terminated by the Company for "cause"
or by Mr. Toth without "good reason", Mr. Toth will only be entitled to the
Accrued Obligations. If Mr. Toth's employment with the Company is terminated by
reason of Mr. Toth's death or "disability" (as defined in the employment
agreement), Mr. Toth is entitled to (A) the Accrued Obligations, (B) a pro rata
portion of his annual bonus, if the Company achieves its performance targets for
the year of such termination, and (C) a continuation of his employee benefits
for the earlier to occur of (i) 12 months, or (ii) an election by Mr. Toth or
his beneficiaries to discontinue coverage.

     The employment agreement contains one year non-competition and
non-solicitation provisions following a termination of employment. The
employment agreement also contains a standard confidentiality provision. If
there is any litigation concerning a breach of the employment agreement, the
prevailing party is entitled to recover all reasonable attorney's fees and costs
from the other party.

Item 5.02. Departure or Principal Officers; Election of Directors; Appointment
           of Principal Officers

     Effective as of July 6, 2005, Robert B. Toth, 44, was appointed Chief
Executive Officer and President of the Company and Chief Executive Officer and
President of the Company's subsidiary, Polypore, Inc. Mr. Toth was also elected
to serve as a member of the Board of Directors of both companies. See Item 1.01
for a description of the terms of the employment agreement and option agreement
entered into between Mr. Toth and the Company.

     Mr. Toth previously was Chief Executive Officer and President of CP Kelco
ApS, a leading global manufacturer of hydrocolloids, with more than 2,000
customers in over 100 countries and facilities in North America, Europe, Asia
and Latin America. Prior to joining CP Kelco in June of 2001, he spent 19 years



at Monsanto and Solutia Inc. in roles of increasing responsibility, most
recently as Vice President and General Manager of the Resins and Additives
division of Solutia.

     Effective as of July 6, 2005, Frank Nasisi has retired from his position as
the Company's Chief Executive Officer and President and as Chief Executive
Officer and President of the Company's subsidiary Polypore, Inc. Mr. Nasisi will
remain on the Board and will continue to provide services to the Company in his
new capacity as the Vice Chairman of the Board.

Item 8.01. Other Events

     On July 7, 2005, the Company issued a press release, attached hereto as
Exhibit 99.1, which is incorporated herein by reference, announcing the
appointment of Mr. Toth to Chief Executive Officer and President of the Company.

Item 9.01. Financial Statements and Exhibits

          (c) Exhibits:

               99.1 Press release issued by the Company on July 7, 2005.


                                      -3-



                                   SIGNATURES



     Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this Report to be signed on its behalf by the
undersigned hereunto duly authorized.







                                        By            /s/ Lynn Amos
                                           -------------------------------------

                                                Name:  Lynn Amos
                                                Title:  Chief Financial Officer



Date:  July 12, 2005


                                      -4-



                                  EXHIBIT INDEX





Exhibit:

99.1 Press release issued by the Company on July 7, 2005.

EX-99.1

                                                                    Exhibit 99.1
                                                                    ------------

                     POLYPORE INTERNATIONAL, INC. APPOINTS
                     ROBERT B. TOTH AS NEW PRESIDENT AND CEO

CHARLOTTE, NC - July 7, 2005 - Polypore International, Inc. announced today that
Robert B. Toth, 44, has been appointed as Polypore International's new President
and Chief Executive Officer and as the new President and Chief Executive Officer
of Polypore International's subsidiary,  Polypore, Inc. Mr. Toth will also serve
as a member of the Board of Directors of both companies.  The current  President
and Chief Executive, Frank Nasisi, will become Vice Chairman and remain a member
of the Board of Directors of both companies.

Mr. Toth previously was President and Chief Executive Officer of CP Kelco ApS, a
leading global manufacturer of hydrocolloids,  with more than 2,000 customers in
over 100  countries  and  facilities in North  America,  Europe,  Asia and Latin
America.  Prior to joining CP Kelco,  he spent 19 years at Monsanto  and Solutia
Inc. in roles of increasing responsibility,  most recently as Vice President and
General Manager of the Resins and Additives division of Solutia.

Michael  Graff,  Warburg Pincus  Managing  Director and Chairman of the Board of
Directors of both Polypore International and Polypore, stated: "We are extremely
pleased to  welcome  Bob as our new  President  and  C.E.O.  He has  substantial
experience  operating global  businesses that sell highly technical  products to
large OEM customers. This experience makes Bob the ideal choice to lead Polypore
into the future. We are also extremely  grateful to Frank for his dedication and
leadership in building  Polypore into the business it is today.  We look forward
to continuing our relationship with him as he assumes his new role."

"I am very pleased to have the  opportunity  to join  Polypore as President  and
C.E.O.  Given  Polypore's  strong  commitment  to  customer  service,   quality,
technical  innovation,  and  delivering  value, I am excited about the promising
growth potential," added Mr. Toth.

Commenting on the  appointment,  Mr. Nasisi added:  "I am proud of what Polypore
has accomplished over the time that I've been affiliated with the company, and I
am very pleased to welcome Bob as Polypore's  new President and C.E.O. I believe
that, given his experience and  qualifications,  he is uniquely equipped to lead
the company into the future."

Polypore International,  Inc. is a growing worldwide developer, manufacturer and
marketer of highly  specialized  polymer-based  membranes used in separation and
filtration  processes.  Polypore's  products and technologies target specialized
applications  and markets  that  require the  removal or  separation  of various
materials  from  liquids,   with  concentration  in  the   ultrafiltration   and
microfiltration  markets.  Truly a global provider,  Polypore has  manufacturing
facilities or sales offices in ten countries serving five continents. Polypore's
corporate offices are located in Charlotte, North Carolina.

This release contains statements that are forward-looking in nature.  Statements
that are  predictive  in nature,  that depend upon or refer to future  events or
conditions or that include words such as  "expects,"  "anticipates,"  "intends,"
"plans,"  "believes,"  "estimates," and similar  expressions are forward-looking
statements.  These statements involve known and unknown risks, uncertainties and
other factors that may cause our actual results and performance to be



materially different from any future results or performance expressed or implied
by these forward-looking  statements.  These factors include the following:  the
highly  competitive  nature of the  markets in which we sell our  products;  the
failure  to  continue  developing  innovative  products;  the  increased  use of
synthetic  hemodialysis  filtration membranes by our customers;  the loss of our
customers;  the vertical  integration  by our customers of the production of our
products  into  their own  manufacturing  process;  increases  in prices for raw
materials or the loss of key supplier contracts;  employee slowdowns, strikes or
similar actions; product liability claims exposure; risks in connection with our
operations  outside the United States;  the  incurrence of substantial  costs to
comply with, or as a result of violations of or liabilities under, environmental
laws; the failure to protect our intellectual  property;  the failure to replace
lost  senior   management;   the  incurrence  of  additional  debt,   contingent
liabilities and expenses in connection with future acquisitions;  the failure to
effectively integrate newly acquired operations; and absence of expected returns
from the amount of intangible  assets we have recorded.  Additional  information
concerning these and other important  factors can be found in the "Risk Factors"
section of Polypore  International's  Registration  Statement  on Form S-4 filed
with the  Securities  and Exchange  Commission  on June 13, 2005 and Polypore `s
Annual Report on Form 10-K for the fiscal year ended January 1, 2005. Statements
in this  release  should  be  evaluated  in light of  these  important  factors.
Although we believe that these statements are based upon reasonable assumptions,
we  cannot   guarantee   future   results.   Given  these   uncertainties,   the
forward-looking statements discussed in this press release might not occur.



CONTACT:   Mark Hadley -  Investor Relations Manager - 704-587-8886


                                     - 2 -